| Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or … JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ... The lancet oncology 16 (2), 187-199, 2015 | 2046 | 2015 |
| Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: A secondary analysis of the NRG oncology RTOG 0617 randomized … SG Chun, C Hu, H Choy, RU Komaki, RD Timmerman, SE Schild, ... Journal of Clinical Oncology 35 (1), 56-62, 2016 | 686 | 2016 |
| Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer Y Yao, X Xu, L Yang, J Zhu, J Wan, L Shen, F Xia, G Fu, Y Deng, M Pan, ... Cell stem cell 26 (1), 17-26. e6, 2020 | 470 | 2020 |
| Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer JD Bradley, C Hu, RR Komaki, GA Masters, GR Blumenschein, SE Schild, ... Journal of Clinical Oncology 38 (7), 706, 2020 | 412 | 2020 |
| A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG … GMM Videtic, C Hu, AK Singh, JY Chang, W Parker, KR Olivier, SE Schild, ... International Journal of Radiation Oncology* Biology* Physics 93 (4), 757-764, 2015 | 326 | 2015 |
| Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial SL Wang, H Fang, YW Song, WH Wang, C Hu, YP Liu, J Jin, XF Liu, ... The Lancet Oncology 20 (3), 352-360, 2019 | 323 | 2019 |
| Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) J Jin, Y Tang, C Hu, LM Jiang, J Jiang, N Li, WY Liu, SL Chen, S Li, NN Lu, ... Journal of Clinical Oncology, JCO. 21.01667, 2022 | 213 | 2022 |
| Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell … RD Timmerman, C Hu, J Michalski, W Straube, J Galvin, D Johnstone, ... International Journal of Radiation Oncology• Biology• Physics 90 (1), S30, 2014 | 205 | 2014 |
| Rate of false conviction of criminal defendants who are sentenced to death SR Gross, B O’Brien, C Hu, EH Kennedy Proceedings of the National Academy of Sciences 111 (20), 7230-7235, 2014 | 205 | 2014 |
| Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer RD Timmerman, C Hu, JM Michalski, JC Bradley, J Galvin, DW Johnstone, ... JAMA oncology 4 (9), 1287-1288, 2018 | 199 | 2018 |
| Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424 BJ Fisher, C Hu, DR Macdonald, GJ Lesser, SW Coons, DG Brachman, ... International Journal of Radiation Oncology* Biology* Physics 91 (3), 497-504, 2015 | 182 | 2015 |
| Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 … B Movsas, C Hu, J Sloan, J Bradley, R Komaki, G Masters, V Kavadi, ... JAMA oncology 2 (3), 359-367, 2016 | 171 | 2016 |
| Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized … Z Hui, Y Men, C Hu, J Kang, X Sun, N Bi, Z Zhou, J Liang, J Lv, Q Feng, ... JAMA oncology 7 (8), 1178-1185, 2021 | 161 | 2021 |
| Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial SA Rosenthal, C Hu, O Sartor, LG Gomella, MB Amin, J Purdy, ... Journal of Clinical Oncology, JCO. 18.02158, 2019 | 151 | 2019 |
| Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease … EM Gore, C Hu, AY Sun, DF Grimm, SS Ramalingam, NE Dunlap, ... Journal of Thoracic Oncology 12 (10), 1561-1570, 2017 | 137 | 2017 |
| A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk … HM Sandler, C Hu, SA Rosenthal, O Sartor, LG Gomella, M Amin, J Purdy, ... Journal of Clinical Oncology 33 (18_suppl), LBA5002-LBA5002, 2015 | 132 | 2015 |
| Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer P Korangath, JD Barnett, A Sharma, ET Henderson, J Stewart, SH Yu, ... Science advances 6 (13), eaay1601, 2020 | 130 | 2020 |
| Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02 RS Prabhu, M Won, EG Shaw, C Hu, DG Brachman, JC Buckner, ... Journal of Clinical Oncology 32 (6), 535, 2014 | 121 | 2014 |
| Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012 HH Pang, X Wang, TE Stinchcombe, ML Wong, P Cheng, AK Ganti, ... Journal of Clinical Oncology 34 (33), 3992, 2016 | 102 | 2016 |
| Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non–Small-Cell Lung Cancer KR Voong, SZ Hazell, W Fu, C Hu, CT Lin, K Ding, K Suresh, J Hayman, ... Clinical lung cancer, 2019 | 101 | 2019 |
Jeffrey BradleyProfessor of Radiation Oncology, Emory UniversityDirección de correo verificada de pennmedicine.upenn.edu
